These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38114842)
1. Severe perioperative lactic acidosis in a pediatric patient with glycogen storage disease type Ia: a case report. Takahashi T; Oue K; Imado E; Doi M; Shimizu Y; Yoshida M JA Clin Rep; 2023 Dec; 9(1):91. PubMed ID: 38114842 [TBL] [Abstract][Full Text] [Related]
2. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using Turki A; Stockler S; Sirrs S; Duddy K; Ho G; Elango R Mol Genet Metab Rep; 2023 Mar; 34():100955. PubMed ID: 36632325 [TBL] [Abstract][Full Text] [Related]
3. Development of minimally invasive Turki A; Stockler S; Sirrs S; Salvarinova R; Ho G; Branov J; Rosen-Heath A; Bosdet T; Elango R Mol Genet Metab Rep; 2022 Jun; 31():100880. PubMed ID: 35585965 [TBL] [Abstract][Full Text] [Related]
4. Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia. Oshita A; Itamoto T; Amano H; Ohdan H; Tashiro H; Asahara T J Hepatobiliary Pancreat Surg; 2008; 15(2):200-3. PubMed ID: 18392715 [TBL] [Abstract][Full Text] [Related]
5. Neonatal Glycogen Storage Disease Type IA: A Rare Presentation. Tenente J; Campos T; Vasconcelos C; Santos H; Carvalho M; Ramos A; Vilarinho L; Rodrigues E; Teles EL Endocr Metab Immune Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37859321 [TBL] [Abstract][Full Text] [Related]
6. Profound neonatal lactic acidosis and renal tubulopathy in a patient with glycogen storage disease type IXɑ2 secondary to a Morales JA; Tise CG; Narang A; Grimm PC; Enns GM; Lee CU Mol Genet Metab Rep; 2021 Jun; 27():100765. PubMed ID: 34277355 [TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study. Shao YX; Liang CL; Su YY; Lin YT; Lu ZK; Lin RZ; Zhou ZZ; Zeng CH; Tao CY; Liu ZC; Zhang W; Liu L Orphanet J Rare Dis; 2024 Apr; 19(1):155. PubMed ID: 38605407 [TBL] [Abstract][Full Text] [Related]
9. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Nagasaka H; Hirano K; Ohtake A; Miida T; Takatani T; Murayama K; Yorifuji T; Kobayashi K; Kanazawa M; Ogawa A; Takayanagi M Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455 [TBL] [Abstract][Full Text] [Related]
10. Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy. Jackson DG; Koch RL; Pendyal S; Benjamin R; Kishnani PS JIMD Rep; 2023 Sep; 64(5):303-311. PubMed ID: 37701330 [TBL] [Abstract][Full Text] [Related]
11. Glycogen Storage Disease type IA refractory to cornstarch: Can next generation sequencing offer a solution? Steg Saban O; Pode-Shakked B; Abu-Libdeh B; Granot M; Barkai G; Haberman Y; Roterman I; Lahad A; Shouval DS; Weiss B; Marek-Yagel D; Barel O; Loberman-Nachum N; Abraham S; Somech R; Weinstein DA; Anikster Y Eur J Med Genet; 2022 Jun; 65(6):104518. PubMed ID: 35550444 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia. La Rose AM; Bazioti V; Hoogerland JA; Svendsen AF; Groenen AG; van Faassen M; Rutten MGS; Kloosterhuis NJ; Dethmers-Ausema B; Nijland JH; Mithieux G; Rajas F; Kuipers F; Lukens MV; Soehnlein O; Oosterveer MH; Westerterp M Mol Metab; 2021 Nov; 53():101265. PubMed ID: 34091064 [TBL] [Abstract][Full Text] [Related]
13. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review. Cho JH; Weinstein DA; Lee YM J Inherit Metab Dis; 2021 Jan; 44(1):118-128. PubMed ID: 32474930 [TBL] [Abstract][Full Text] [Related]
14. Obesity and reversed growth retardation in a child with type Ia glycogen storage disease. Karnsakul W; Gillespie S; Skitarelic K; Hummel M J Pediatr Endocrinol Metab; 2010 May; 23(5):507-12. PubMed ID: 20662351 [TBL] [Abstract][Full Text] [Related]
15. A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report. Wang W; Yu R; Tan W; Dan Y; Deng G; Xia J BMC Med Genet; 2019 May; 20(1):85. PubMed ID: 31109299 [TBL] [Abstract][Full Text] [Related]
16. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Matern D; Seydewitz HH; Bali D; Lang C; Chen YT Eur J Pediatr; 2002 Oct; 161 Suppl 1():S10-9. PubMed ID: 12373566 [TBL] [Abstract][Full Text] [Related]
17. A 20-year follow-up of a male patient with type Ia glycogen storage disease. Hou JW; Wang TR Chang Gung Med J; 2003 Apr; 26(4):283-7. PubMed ID: 12846528 [TBL] [Abstract][Full Text] [Related]
18. Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review. Dahlberg KR; Ferrecchia IA; Dambska-Williams M; Resler TE; Ross KM; Butler GL; Kuo CL; Ryan PT; Weinstein DA J Inherit Metab Dis; 2020 Mar; 43(2):269-278. PubMed ID: 31415093 [TBL] [Abstract][Full Text] [Related]
19. Impact of glycogen storage disease type I on adult daily life: a survey. Garbade SF; Ederer V; Burgard P; Wendel U; Spiekerkoetter U; Haas D; Grünert SC Orphanet J Rare Dis; 2021 Sep; 16(1):371. PubMed ID: 34479584 [TBL] [Abstract][Full Text] [Related]